Skip to Main Content

Our team draws from a deep bench of dedicated employee benefits and executive compensation practitioners, each of whom is experienced in counseling clients in mergers and acquisitions (M&A). We are uniquely positioned to provide comprehensive and cost-effective employee benefits-related transactional support.

Working closely with BakerHostetler’s Business Group, we advise clients across a diverse range of sectors, including private equity funds and public and private businesses, in all stages of M&A transactions, large and small.

We take a practical, business-focused approach to employee benefits-related issues and opportunities that arise in M&A deals. While it is important for companies to understand the implications of benefits issues, we know that it is vital to suggest and implement practical solutions focused on our clients’ broader business goals. We do this by:


  • Worked on the employee benefits aspects of multibillion-dollar acquisitions and divestitures for a multinational food and beverage company, including the acquisition of a division of a global pharmaceutical corporation.
  • Worked on all facets of employee benefits issues in acquisitions and divestitures for venture capital firms and developed a sensitivity to matters that are important to such firms.
  • Guided large manufacturing clients through employee benefits due diligence and pre- and post-closing benefits transition issues as part of numerous acquisitions.
  • Worked with a client to form and establish new health and welfare and retirement plans as part of a billion-dollar corporate spinoff transaction.
  • Assisted with post-closing retirement and health and welfare plan corrections, including related corrective filings through the IRS Voluntary Correction Program and the Department of Labor Voluntary Fiduciary Correction Program.
  • Worked for an insurance company providing representation and warranty insurance to various buyers and sellers in M&A transactions.
  • Provided counsel regarding employee benefits and workforce transition issues for a major medical company engaged in five acquisitions and dispositions totaling nearly $4 billion in value.

Featured Insights